Racepoint Group Appointed by VolitionRX to Raise Awareness of Its New Early-Stage Cancer Diagnostic
5/1/2013 9:44:38 AM
More...
|
VolitionRX Files Two Patent Applications
4/4/2013 9:27:21 AM
More...
|
VolitionRX Hires Head of US Operations, Jason Terrell MD
3/26/2013 6:41:49 AM
More...
|
VolitionRX Announces Collaboration With Wales Cancer Bank
1/9/2013 9:23:30 AM
More...
|
VolitionRX Launches NuQ® Epigenetic Immunoassays for Research Use
12/17/2012 8:43:42 AM
More...
|
VolitionRX's Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers
11/5/2012 10:47:51 AM
More...
|
VolitionRX to Begin Prospective Clinical Trial in Colon Cancer
8/21/2012 10:11:28 AM
More...
|
VolitionRX Issues CEO Letter to Shareholders
7/16/2012 10:07:52 AM
More...
|
VolitionRX Signs Collaboration Agreement With Stefan Holdenrieder of Rheinische Friedrich-Wilhelms-Universitat Bonn Germany
7/9/2012 10:35:48 AM
More...
|
VolitionRX Raises Over $1 Million to Begin Clinical Trials of Blood Based Diagnostic Tests
5/14/2012 11:51:02 AM
More...
|
|